BOLAGSKÄLLOR

Royalty Pharma plc

Statiskt källarkiv med kurshistorik, finansiella rapporter och regulatoriska dokument. För nordiska bolag används Nasdaq Nordic primärt och MFN endast för saknade rapportperioder.

Slug: royalty-pharma-plc Dokument: 17 Status: complete
Nasdaq marknadsdataretrieved2026-08-05: stängning 57.75, volym 3536502
Finansiella rapporter 0 0 Nasdaq primär · 0 MFN fallback
SEC EDGARretrieved81 arkiverade filings

Källidentiteter

Kontrollera dessa identiteter innan data används i en värdering.

Visa verifierad/resolverad metadata
{
  "finansinspektionen": null,
  "mfn": null,
  "nasdaq": null,
  "nasdaq_reports": null,
  "sec": {
    "cik": "0001802768",
    "expected_name": "Royalty Pharma plc",
    "match_score": 100.0,
    "method": "explicit_ticker",
    "status": "resolved",
    "ticker": "RPRX",
    "title": "Royalty Pharma plc"
  }
}

Snabblänkar för ChatGPT och andra läsare

Bolagets llms.txt · company.json · documents.json · reports.json

Nasdaq kurshistorik CSV · Nasdaq kurshistorik JSON · Nasdaq manifest JSON · SEC Company Facts JSON · SEC filing-manifest JSON · SEC sammanfattning JSON

SEC Company Facts – strukturerade nyckeltal

Värdena kommer direkt från emittentens XBRL-facts. Samma begrepp kan ändra definition mellan perioder; läs alltid den officiella filing-texten.

Intäkter – us-gaap:Revenues
PeriodFormVärdeEnhetInlämnad
2026-06-3010-Q1304717000USD2026-08-05
2025-06-3010-Q1146912000USD2026-08-05
2026-03-3110-Q630576000USD2026-05-06
2025-03-3110-Q568247000USD2026-05-06
2025-12-3110-K2378193000USD2026-02-11
2024-12-3110-K2263576000USD2026-02-11
2023-12-3110-K2354554000USD2026-02-11
2025-09-3010-Q1756203000USD2025-11-05
2024-09-3010-Q1669935000USD2025-11-05
2025-06-3010-Q1146912000USD2025-08-06
2024-06-3010-Q1105245000USD2025-08-06
2025-03-3110-Q568247000USD2025-05-08
2024-03-3110-Q567978000USD2025-05-08
2024-12-3110-K2263576000USD2025-02-12
2023-12-3110-K2354554000USD2025-02-12
2022-12-3110-K2237215000USD2025-02-12
Rörelseresultat – us-gaap:OperatingIncomeLoss
PeriodFormVärdeEnhetInlämnad
2026-06-3010-Q696156000USD2026-08-05
2025-06-3010-Q743980000USD2026-08-05
2026-03-3110-Q563038000USD2026-05-06
2025-03-3110-Q534182000USD2026-05-06
2025-12-3110-K1559518000USD2026-02-11
2024-12-3110-K1292444000USD2026-02-11
2023-12-3110-K1492150000USD2026-02-11
2025-09-3010-Q1171136000USD2025-11-05
2024-09-3010-Q930930000USD2025-11-05
2025-06-3010-Q743980000USD2025-08-06
2024-06-3010-Q195856000USD2025-08-06
2025-03-3110-Q534182000USD2025-05-08
2024-03-3110-Q-73774000USD2025-05-08
2024-12-3110-K1292444000USD2025-02-12
2023-12-3110-K1492150000USD2025-02-12
2022-12-3110-K307065000USD2025-02-12
Nettoresultat – us-gaap:NetIncomeLoss
PeriodFormVärdeEnhetInlämnad
2026-06-3010-Q312572000USD2026-08-05
2025-06-3010-Q271525000USD2026-08-05
2026-03-3110-Q294690000USD2026-05-06
2025-03-3110-Q239349000USD2026-05-06
2025-12-3110-K770947000USD2026-02-11
2024-12-3110-K858983000USD2026-02-11
2023-12-3110-K1134834000USD2026-02-11
2025-09-3010-Q556742000USD2025-11-05
2024-09-3010-Q650769000USD2025-11-05
2025-06-3010-Q268525000USD2025-08-06
2024-06-3010-Q106782000USD2025-08-06
2025-03-3110-Q238349000USD2025-05-08
2024-03-3110-Q4778000USD2025-05-08
2024-12-3110-K858983000USD2025-02-12
2023-12-3110-K1134834000USD2025-02-12
2022-12-3110-K42832000USD2025-02-12
Resultat per aktie, utspätt – us-gaap:EarningsPerShareDiluted
PeriodFormVärdeEnhetInlämnad
2026-06-3010-Q0.71USD/shares2026-08-05
2025-06-3010-Q0.63USD/shares2026-08-05
2026-03-3110-Q0.67USD/shares2026-05-06
2025-03-3110-Q0.55USD/shares2026-05-06
2025-12-3110-K1.78USD/shares2026-02-11
2024-12-3110-K1.91USD/shares2026-02-11
2023-12-3110-K2.53USD/shares2026-02-11
2025-09-3010-Q1.28USD/shares2025-11-05
2024-09-3010-Q1.44USD/shares2025-11-05
2025-06-3010-Q0.62USD/shares2025-08-06
2024-06-3010-Q0.24USD/shares2025-08-06
2025-03-3110-Q0.55USD/shares2025-05-08
2024-03-3110-Q0.01USD/shares2025-05-08
2024-12-3110-K1.91USD/shares2025-02-12
2023-12-3110-K2.53USD/shares2025-02-12
2022-12-3110-K0.1USD/shares2025-02-12
Kassa – us-gaap:CashAndCashEquivalentsAtCarryingValue
PeriodFormVärdeEnhetInlämnad
2026-06-3010-Q811986000USD2026-08-05
2025-12-3110-Q618696000USD2026-08-05
2026-03-3110-Q586395000USD2026-05-06
2025-12-3110-Q618696000USD2026-05-06
2025-12-3110-K618696000USD2026-02-11
2024-12-3110-K929026000USD2026-02-11
2025-09-3010-Q938944000USD2025-11-05
2024-12-3110-Q929026000USD2025-11-05
2025-06-3010-Q631908000USD2025-08-06
2024-12-3110-Q929026000USD2025-08-06
2025-03-3110-Q1087720000USD2025-05-08
2024-12-3110-Q929026000USD2025-05-08
2024-12-3110-K929026000USD2025-02-12
2023-12-3110-K477010000USD2025-02-12
2024-09-3010-Q950052000USD2024-11-06
2023-12-3110-Q477010000USD2024-11-06
Tillgångar – us-gaap:Assets
PeriodFormVärdeEnhetInlämnad
2026-06-3010-Q19819771000USD2026-08-05
2025-12-3110-Q19620780000USD2026-08-05
2026-03-3110-Q19815415000USD2026-05-06
2025-12-3110-Q19620780000USD2026-05-06
2025-12-3110-K19620780000USD2026-02-11
2024-12-3110-K18222715000USD2026-02-11
2025-09-3010-Q19347280000USD2025-11-05
2024-12-3110-Q18222715000USD2025-11-05
2025-06-3010-Q18323000000USD2025-08-06
2024-12-3110-Q18222715000USD2025-08-06
2025-03-3110-Q17608256000USD2025-05-08
2024-12-3110-Q18222715000USD2025-05-08
2024-12-3110-K18222715000USD2025-02-12
2023-12-3110-K16381851000USD2025-02-12
2024-09-3010-Q18042242000USD2024-11-06
2023-12-3110-Q16381851000USD2024-11-06
Skulder – us-gaap:Liabilities
PeriodFormVärdeEnhetInlämnad
2026-06-3010-Q10034057000USD2026-08-05
2025-12-3110-Q9905841000USD2026-08-05
2026-03-3110-Q9878582000USD2026-05-06
2025-12-3110-Q9905841000USD2026-05-06
2025-12-3110-K9905841000USD2026-02-11
2024-12-3110-K7880349000USD2026-02-11
2025-09-3010-Q9726419000USD2025-11-05
2024-12-3110-Q7880349000USD2025-11-05
2025-06-3010-Q8820060000USD2025-08-06
2024-12-3110-Q7880349000USD2025-08-06
2025-03-3110-Q7819599000USD2025-05-08
2024-12-3110-Q7880349000USD2025-05-08
2024-12-3110-K7880349000USD2025-02-12
2023-12-3110-K6297562000USD2025-02-12
2024-09-3010-Q7783775000USD2024-11-06
2023-12-3110-Q6297562000USD2024-11-06
Eget kapital – us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
PeriodFormVärdeEnhetInlämnad
2026-06-3010-Q9785714000USD2026-08-05
2026-03-3110-Q9936833000USD2026-08-05
2025-12-3110-Q9714939000USD2026-08-05
2025-06-3010-Q9493940000USD2026-08-05
2025-03-3110-Q9777657000USD2026-08-05
2024-12-3110-Q10342366000USD2026-08-05
2026-03-3110-Q9936833000USD2026-05-06
2025-12-3110-Q9714939000USD2026-05-06
2025-03-3110-Q9777657000USD2026-05-06
2024-12-3110-Q10342366000USD2026-05-06
2025-12-3110-K9714939000USD2026-02-11
2024-12-3110-K10342366000USD2026-02-11
2023-12-3110-K10084289000USD2026-02-11
2022-12-3110-K9525373000USD2026-02-11
2025-09-3010-Q9620861000USD2025-11-05
2025-06-3010-Q9502940000USD2025-11-05
Operativt kassaflöde – us-gaap:NetCashProvidedByUsedInOperatingActivities
PeriodFormVärdeEnhetInlämnad
2026-06-3010-Q1446694000USD2026-08-05
2025-06-3010-Q960060000USD2026-08-05
2026-03-3110-Q718233000USD2026-05-06
2025-03-3110-Q596076000USD2026-05-06
2025-12-3110-K2489823000USD2026-02-11
2024-12-3110-K2768986000USD2026-02-11
2023-12-3110-K2987802000USD2026-02-11
2025-09-3010-Q1662675000USD2025-11-05
2024-09-3010-Q2026461000USD2025-11-05
2025-06-3010-Q960060000USD2025-08-06
2024-06-3010-Q1322847000USD2025-08-06
2025-03-3110-Q596076000USD2025-05-08
2024-03-3110-Q664638000USD2025-05-08
2024-12-3110-K2768986000USD2025-02-12
2023-12-3110-K2987802000USD2025-02-12
2022-12-3110-K2143980000USD2025-02-12
Antal aktier, utspätt – us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
PeriodFormVärdeEnhetInlämnad
2026-06-3010-Q557352000shares2026-08-05
2025-06-3010-Q570157000shares2026-08-05
2026-03-3110-Q556837000shares2026-05-06
2025-03-3110-Q578102000shares2026-05-06
2025-12-3110-K564455000shares2026-02-11
2024-12-3110-K594108000shares2026-02-11
2023-12-3110-K602900000shares2026-02-11
2025-09-3010-Q566754000shares2025-11-05
2024-09-3010-Q595683000shares2025-11-05
2025-06-3010-Q570157000shares2025-08-06
2024-06-3010-Q597195000shares2025-08-06
2025-03-3110-Q578102000shares2025-05-08
2024-03-3110-Q597479000shares2025-05-08
2024-12-3110-K594108000shares2025-02-12
2023-12-3110-K602900000shares2025-02-12
2022-12-3110-K437972000shares2025-02-12

Dokument i fulltext